We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Haley Perry Haley Perry is a staff writer focused on video games and booze.
You can trust VideoGamer. Our team of gaming experts spend hours testing and reviewing the latest games, to ensure you're reading the most comprehensive guide possible. Rest assured, all imagery and ...
In the digital battleground of “Battlefield 6”, a storm brews over the use of Cronus Zen, a device notorious among gamers for its capacity to manipulate gameplay through scripts and macros. This ...
Battlefield 6 is reportedly banning players detected using Cronus Zen devices across both PC and consoles. The purported move sparked some controversy on social media, positioning Battlefield 6 as one ...
Cronus Zen cheaters in Battlefield 6 are receiving temporary bans for abusing the game using cheating hardware. Battlefield 6 developers implemented anti-cheat measures for Windows PC players, making ...
Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and began doing so professionally circa 2010. If he was forced to pick a favorite ...
As spotted by members of the Battlefield 6 community online, reports from users of the Cronus Zen getting temporary bans for using the cheating hardware are circulating online, but the full scope of ...
While most cheaters are on PC thanks to the platform’s open-ended nature and how easy it is to run software parallel to the game to do something nefarious, console gamers are also seeing an uptick of ...
Cronus Chemicals LLC will invest $2 billion to construct a new fertilizer production facility in Tuscola, Illinois. Supported by Illinois Department of Commerce and Economic Opportunity (DCEO) with an ...
DECATUR, Ill. (WAND) - Governor JB Pritzker and the Illinois Department of Commerce and Economic Opportunity announced a $2 billion investment from Cronus Chemicals LLC (Cronus) to construct a new ...
Cronus Pharma, an animal healthcare company that top Indian drugmaker Aurobindo Pharma wanted to acquire in 2021 before cancelling the deal, has now attracted interest from a few private equity ...